Literature DB >> 4000477

Ultrastructural features of a human neuroblastoma cell line treated with retinoic acid.

J A Robson, N Sidell.   

Abstract

This report examines the morphological changes that occur in a line of human neuroblastoma cells (LA-N-5) following treatment with retinoic acid, in vitro. The results demonstrate that retinoic acid induces pronounced differentiation of these cells. Perikarya aggregate into tight clusters and extend long processes that are frequently fasciculated. Growth cones appear at the ends of these processes. Transmission electron microscopy reveals that after 10 days of treatment these long neurites give rise to varicosities which contain clusters of large dense-core vesicles and smaller clear vesicles. After 18 days of treatment the cultures cease to differentiate further. The pattern of neurite outgrowth is very complex by this point and the frequency of growth cones and vesicle-containing varicosities is greatly increased compared with shorter treatments. Most of these varicosities contain a mix of large dense-core vesicles and smaller clear vesicles and in some profiles the clear vesicles are round while in others they are pleomorphic. Despite this increase in the number of vesicle-containing profiles no membrane specializations were seen that resemble mature synapses. The present results demonstrate that retinoic acid can produce morphological changes in these cells in culture, and that these changes closely mimic those of normal differentiating neurons in culture. Considered with previous studies, these findings suggest that this cell line might provide a useful model system for studying neural differentiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4000477     DOI: 10.1016/0306-4522(85)90284-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  Decreased expression of the voltage-dependent anion channel in differentiated PC-12 and SH-SY5Y cells following low-level Pb exposure.

Authors:  John M Prins; Sunyoung Park; Diana I Lurie
Journal:  Toxicol Sci       Date:  2009-10-12       Impact factor: 4.849

2.  Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.

Authors:  Raoud Marayati; Adele P Williams; Laura V Bownes; Colin H Quinn; Jerry E Stewart; Elizabeth Mroczek-Musulman; Venkatram R Atigadda; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2020-02-28       Impact factor: 2.545

3.  Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.

Authors:  Alicia M Waters; Jerry E Stewart; Venkatram R Atigadda; Elizabeth Mroczek-Musulman; Donald D Muccio; Clinton J Grubbs; Elizabeth A Beierle
Journal:  Mol Cancer Ther       Date:  2015-05-05       Impact factor: 6.261

4.  UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.

Authors:  Evan F Garner; Laura L Stafman; Adele P Williams; Jamie M Aye; Caroline Goolsby; Venkatram R Atigadda; Blake P Moore; Li Nan; Jerry E Stewart; Anita B Hjelmeland; Gregory K Friedman; Elizabeth A Beierle
Journal:  J Neurooncol       Date:  2018-08-21       Impact factor: 4.130

5.  Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.

Authors:  Yanlin Zhao; Xiao Zhong; Xiaohong Ou; Huawei Cai; Xiaoai Wu; Rui Huang
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

6.  Medulloblastoma with extensive nodularity: single photon emission CT study with iodine-123 metaiodobenzylguanidine.

Authors:  Yuichiro Naitoh; Toshio Sasajima; Hiroyuki Kinouchi; Shigeki Mikawa; Kazuo Mizoi
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

7.  CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation.

Authors:  Nandini Dey; Pradip K De; Mu Wang; Hongying Zhang; Erika A Dobrota; Kent A Robertson; Donald L Durden
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

Review 8.  Differentiation therapy revisited.

Authors:  Hugues de Thé
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

9.  Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts.

Authors:  Raoud Marayati; Laura V Bownes; Colin H Quinn; Nikita Wadhwani; Adele P Williams; Hooper R Markert; Venkatram Atigadda; Jamie M Aye; Jerry E Stewart; Karina J Yoon; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2021-02-24       Impact factor: 2.549

10.  Sodium currents during differentiation in a human neuroblastoma cell line.

Authors:  R E Weiss; N Sidell
Journal:  J Gen Physiol       Date:  1991-03       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.